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OBJECTIVES We sought to identify the incidence, predictors, and clinical implications of cerebrovascular
accidents (CVAs) after percutaneous coronary interventions (PCIs).
BACKGROUND Cerebrovascular accidents after PCI, although rare, can be devastating. Limited information
exists regarding the characterization of this complication.
METHODS The study population comprised 20,679 patients who underwent PCI between September
1993 and April 2002. A CVA was defined as a composite of transient ischemic attack (TIA)
and stroke. The characteristics of those who had a periprocedural CVA were compared with
those who did not.
RESULTS A CVA occurred in 92 patients (0.30% of procedures). Of these, TIA occurred in 13 patients
(0.04%) and stroke in 79 patients (0.25%). On multivariate analysis, patients with this
complication more frequently had diabetes mellitus (adjusted odds ratio [OR] 1.8, 95%
confidence interval [CI] 1.1 to 3.0; p  0.013), hypertension (OR 1.9, 95% CI 1.1 to 3.3; p
 0.033), previous CVA (OR 2.3, 95% CI 1.3 to 4.0; p  0.0059), and creatinine clearance
40 ml/min (OR 3.1, 95% CI 1.8 to 5.2; p  0.0001). They underwent urgent or emergent
procedures (OR 2.7, 95% CI 1.3 to 5.5; p  0.0092) with more thrombolytic (OR 4.7, 95%
CI 2.3 to 9.7; p  0.0001) and intravenous heparin (OR 1.9, 95% CI 1.1 to 3.4; p  0.030)
use before PCI, and they more often required emergent intra-aortic balloon pump placement
(OR 2.2, 95% CI 1.1 to 4.3; p  0.028). On multivariate analysis, CVA was independently
associated with in-hospital death (OR 7.8, 95% CI 4.2 to 14.7; p  0.0001), acute renal
failure (OR 2.8, 95% CI 1.4 to 5.7; p  0.0042), and new dialysis (OR 3.73, 95% CI 1.01
to 13.8; p  0.049) after PCI.
CONCLUSIONS Cerebrovascular accidents after PCI, although rare, are associated with high rates of
in-hospital death and acute renal failure, often requiring dialysis. (J Am Coll Cardiol 2004;
43:1161–7) © 2004 by the American College of Cardiology FoundationM
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tcute cerebrovascular accidents (CVAs) after percutaneous
oronary interventions (PCIs), although rare, are associated
ith high rates of mortality and morbidity (1–6). Although
revious studies have been predominantly limited to the
haracterization of stroke after PCI, few have included
ransient ischemic attacks (TIAs) in their analyses (6). The
See page 1168
ncidence of these combined cerebrovascular complications
as been reported to range from 0.27% to 0.50% (1,2). The
ow incidence of these complications has limited the ability
f previous studies to adequately characterize stroke and
IA after PCI. Therefore, we sought to identify the
ncidence, predictors, and in-hospital outcomes of these
ombined complications in 20,679 consecutive patients who
nderwent PCI at a single, large-volume center.
From the *Division of Cardiology and †Department of Radiology, William
eaumont Hospital, Royal Oak, Michigan. This study was presented in part as an
bstract at the American College of Cardiology Scientific Sessions in Chicago,
llinois, in March 2003.
Manuscript received July 30, 2003; revised manuscript received October 30, 2003,
pccepted November 3, 2003.ETHODS
efinition of CVA. A CVA was defined as the onset of a
ew neurologic deficit that occurred anytime after PCI
uring the index hospitalization. If the duration of the
eficit was 24 h, it was defined as a TIA. If the deficit
ersisted for a longer period, it was defined as a stroke. The
iagnosis of CVA was made by experienced neurologists.
tudy population. The clinical, angiographic, and in-
ospital outcomes of all patients who had PCI from
eptember 1993 through April 2002 at the William Beau-
ont Hospital were stored prospectively in a database. The
34 PCI patients who also underwent coronary artery
ypass grafting during the index hospitalization were ex-
luded. None of the excluded patients suffered a CVA
efore surgery. The remaining 20,679 patients underwent
0,998 PCI procedures during this time period. In patients
ith multiple procedures, only data from the last visit were
sed in subsequent analyses. However, if a CVA occurred in
hospital stay other than the last one, then data from that
isit were used instead. The clinical and angiographic
eatures, as well as in-hospital outcomes of the patients who
uffered an in-hospital CVA after PCI, were compared with
hose who did not.
A retrospective chart review of all CVA patients was
erformed to obtain information that was unavailable in the
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Cerebrovascular Events After Angioplasty April 7, 2004:1161–7omputer database. The information collected in this man-
er consisted of presenting with neurologic deficits, time of
nset after PCI, neurologists’ clinical diagnosis, type and
ocation of CVA, duration of deficits, and disposition at
ospital discharge. Most patients had computed tomogra-
hy or magnetic resonance imaging studies of the brain
erformed and interpreted at the time of hospitalization by
ndependent neuroradiologists. Based on their reports, an-
ther experienced neuroradiologist retrospectively classified
he stroke type (ischemic or hemorrhagic) and location (e.g.,
rontal, parietal). If the findings reported by the indepen-
ent neuroradiologists were questionable or negative, the
maging studies were reviewed again for confirmation and
lassification of CVA.
ther definitions. The baseline creatinine clearance was
alculated using the Cockcroft-Gault equation (7). Urgent
CI was defined as PCI in hemodynamically stable patients
uring hospitalization for unstable angina or non–Q-wave
yocardial infarction (NQMI). Emergent PCI was defined
s immediate PCI for acute ST-segment elevation myocar-
ial infarction (MI) or a hemodynamically unstable acute
oronary syndrome. Post-PCI NQMI was defined as the
resence of two of the following three criteria: prolonged
hest pain, elevation of serum creatine kinase 3 times the
pper limit of normal, or electrocardiographic (ECG)
hanges suggesting ischemia. Q-wave MI after PCI was
efined as the presence of two of the three aforementioned
riteria and the appearance of new pathologic Q waves on
2 contiguous ECG leads. Acute renal failure after PCI
as defined as 1 mg/dl elevation in serum creatinine
bove the baseline value before PCI.
tatistics. All statistical analyses were performed using
AS version 8.0 software (Cary, North Carolina). Contin-
ous variables are expressed as the mean value  SD.
omparisons between groups were performed using the
tudent t test. Categorical variables are expressed as counts
nd percent frequencies and were compared using the
hi-square test. Comparisons between the three types of
VA were made using a Kruskal-Wallis test for continuous
ariables and a chi-square test for categorical variables, if
ppropriate (expected frequency 5). Otherwise, the Fisher
xact test was used. Step-down multivariate logistic regres-
ion analysis was performed to identify independent predic-
ors of in-hospital CVA. Variables with a univariate relation
Abbreviations and Acronyms
CI  confidence interval
CVA  cerebrovascular accident
IABP  intra-aortic balloon pump
MI  myocardial infarction
NQMI  non–Q-wave myocardial infarction
OR  odds ratio
PCI  percutaneous coronary intervention
TIA  transient ischemic attackp  0.05) with CVA or thought to be important were ancluded in the model. The C statistic was used to deter-
ine the discriminatory power of the model. The C statistic
s a rank-correlation index that measures the association
etween predicted probabilities and observed responses. A
erfect correlation would be 1. The adjusted odds ratio
OR) and 95% confidence interval (CI) were calculated for
ach variable in the final model. Furthermore, we performed
ultiple logistic regression to assess the independent impact
f in-hospital CVA on clinical outcomes (death, renal
nsufficiency, and new dialysis).
ESULTS
aseline patient characteristics. In-hospital CVA after
CI occurred in 92 of 20,679 patients (0.30% of procedures).
f these, a TIA occurred in 13 (0.04%) patients and stroke in
9 (0.25%) patients. The incidence of CVA after PCI was
ignificantly higher in the period before 1998 compared with
998 and after (0.39% vs. 0.22%, p  0.0075). The baseline
linical differences between patients who had a periprocedural
VA and those who did not are shown in Table 1. Patients
ith a CVA were older females with a smaller body surface
rea. Those with CVA more often had a history of hyperten-
ion, diabetes mellitus, congestive heart failure, previous CVA,
eripheral vascular disease, and worse baseline renal function,
s measured by creatinine clearance. Cardiac catheterization
as more often urgent or emergent in the CVA group, with a
ignificantly greater prior use of intravenous heparin and
hrombolytics.
ata on PCI. As shown in Table 2, patients who had a CVA
nderwent longer cardiac catheterization procedures with more
odinated contrast. Saphenous vein graft PCI was more fre-
uent (15% vs. 7%, p  0.003) with a trend toward more left
ain artery interventions (4.4% vs. 1.8%, p  0.09) in the
VA group. Endotracheal intubation and an intra-aortic
alloon pump (IABP) were needed in 11% and 20% of this
roup, respectively. However, there were no significant differ-
nces in the rates of no reflow, coronary perforation, or abrupt
losure. No significant differences were observed in the maxi-
um activated clotting time or glycoprotein IIb/IIIa use.
linical presentation and CVA characteristics. The most
ommon presenting neurologic manifestations in patients
ith CVA were motor or speech deficits (Table 3). The
ombination of unresponsiveness or altered mental status
ccurred in 45% of all CVA patients and together repre-
ented the most frequently reported deficits. Of the 92
atients who were diagnosed with a CVA, 4 patients had
evere internal carotid artery stenosis that was diagnosed
fter the onset of symptoms. All four of them were
iagnosed by carotid Doppler ultrasound examinations.
hree of these patients had a TIA and one had a stroke. In
ll cases, the presenting symptoms could be localized to the
psilateral hemisphere as the stenosis. Fifty-seven (62%)
atients manifested neurologic deficits within the first 24 h
fter PCI. Seventeen (18%) patients presented between 24
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April 7, 2004:1161–7 Cerebrovascular Events After Angioplastynd 48 h and 18 patients (20%) presented after 48 h
ollowing PCI.
Thirteen patients had a TIA and 79 had a stroke (Fig. 1).
f the 12 TIA patients who underwent neuroimaging, 2
ad acute ischemic infarcts (1 in the distribution of the
iddle cerebral artery and 1 in the distribution of the
osterior cerebral artery), and the other 10 had no imaging
bnormalities. Delayed computed tomographic scans were
ot routinely performed and may have identified a greater
umber of patients with infarcts. In the 71 stroke patients
ho underwent an imaging study, the infarct location could
e attributed to the following artery distributions: middle
erebral in 56%, anterior cerebral in 2%, posterior cerebral in
7%, superior cerebellar in 5%, posterior inferior cerebellar
n 5%, and basilar in 7%. Infarcts to the anterior circulation
epresented 58% and those to the posterior circulation
epresented 54% of the infarcts. Three of the 43 patients
7%) with stroke and evidence of infarct on neuroimaging
ad infarcts involving more than one artery distribution.
emorrhage occurred in the following locations: temporal-
arietal-occipital lobes in 36%, frontal lobe in 27%, basal
anglia in 9%, intraventricular hemorrhage in 46%, subdural
emorrhage in 36%, epidural hemorrhage in 18%, and
ubarachnoid hemorrhage in 46%.
n-hospital outcomes. Death occurred in 25% of those with
VA, compared with 1.5% of those without CVA (p 
Table 1. Baseline Clinical Characteristics
No
(n 
Age (yrs) 65
Females (%) 3
Weight (kg) 84
Body surface area (m2) 1.96
Hypertension (%) 6
Hypercholesterolemia (%) 6
Diabetes mellitus (%) 2
Previous PCI (%) 3
Previous CABG (%) 2
Peripheral vascular disease (%) 1
Tobacco use (%) 2
Previous CVA (%)
Congestive heart failure (%) 1
COPD (%) 1
Aortic valve disease (%)
Baseline hematocrit (%) 40
Creatinine (mg/dl) 1.2
Creatinine clearance (ml/min) 77
Dialysis (%)
Acute myocardial infarction (%) 1
Indication for PCI
Elective (%) 4
Urgent (%) 4
Emergent (%) 1
Thrombolytics before PCI (%)
Heparin before PCI (%) 3
Data are presented as the mean value  SD or percentage o
CABG  coronary artery bypass graft surgery; COPD 
accident; PCI  percutaneous coronary intervention..0001). None of the deaths occurred in those with a TIA.owever, 69% of patients with hemorrhagic stroke and 21% of
atients with ischemic stroke died in the hospital. Patients with
VA had a higher incidence of acute renal failure (15% vs.
.6%, p  0.0001) and new dialysis (4.4% vs. 0.3%, p 
.0001), compared with those who did not suffer this compli-
ation. Although recurrent angina within the first 24 h after
CI was more frequent in the CVA group (7.6% vs. 2.4%, p
.0072), there were no differences in the rates of NQMI (1.1%
s. 0.7%, p  0.46) and Q-wave MI (0% vs. 0.3%, p  1.00).
CVA was also associated with a longer length of hospital
tay (10.3  8.7 vs. 2.4  4.5 days, p  0.0001).
ultivariate predictors of CVA. Independent predictors
f in-hospital CVA, with their respective adjusted OR and
5% CI, are shown in Figure 2. Included in the multivariate
nalysis were age 70 years, gender, body surface area,
iabetes mellitus, hypertension, hypercholesterolemia, con-
estive heart failure, previous CVA or PCI, creatinine
learance40 ml/min, peripheral vascular disease, urgent or
mergent catheterization, thrombolytic or heparin use be-
ore PCI, fluoroscopy time, contrast amount, coronary
erforations, no reflow, intervention to saphenous vein
raft, planned or unplanned IABP use, and year prior to
998. As there were changes in anticoagulation strategies
ith increasing glycoprotein IIb/IIIa use and decreasing
ostprocedural heparin use around 1998, this year was used
o divide the study population. The C statistic for the model
as 0.80, illustrating good discriminatory power. All of
7)
CVA
(n  92) p Value
70  12 0.0001
46 0.0060
77  20 0.0011
7 1.85  0.27 0.0002
75 0.037
47 0.0006
39 0.0083
26 0.026
25 0.26
24 0.017
18 0.57
21 0.0001
29 0.0001
12 0.84
3.3 0.18
38  6 0.0004
1.4  1.0 0.060
61  35 0.0001
1.1 1.00
29 0.0001
0.0001
13.0
55.4
31.5
15 0.0001
67 0.0001
nts.
nic obstructive pulmonary disease; CVA  cerebrovascularCVA
20,58
 12
2
 19
 0.2
5
4
7
7
0
5
1
9
3
3
1.6
 5
 1.0
 35
1.2
1
7.6
2.4
0.1
3
4
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Cerebrovascular Events After Angioplasty April 7, 2004:1161–7hese variables and in-hospital CVA were used to determine
he independent predictors of in-hospital death, acute renal
ailure, and new dialysis after PCI. A CVA was indepen-
ently associated with in-hospital death (OR 7.8, 95% CI
.2 to 14.7; p  0.0001), acute renal failure (OR 2.8, 95%
I 1.4 to 5.7; p  0.0042), and new dialysis (OR 3.73, 95%
I 1.01 to 13.8; p  0.049). The C statistic was 0.91 for
eath, 0.92 for acute renal failure, and 0.94 for new dialysis.
ifferences based on type of CVA. Most of the baseline
linical and cardiac intervention characteristics were not
ifferent between those who had a hemorrhagic stroke,
Table 2. Percutaneous Coronary Intervention C
Target artery
LMCA (%)
LAD (%)
LCx (%)
RCA (%)
SVG (%)
PCI type
Balloon angioplasty (%)
Stent (%)
Laser (%)
Atherectomy (%)
TEC (%)
Maximum ACT (s)
Glycoprotein IIb/IIIa (%)
Total contrast (ml)
Fluoroscopy time (min)
Catheterization laboratory complications
Shock (%)
Endotracheal intubation (%)
No reflow (%)
Coronary perforation (%)
Abrupt closure (%)
IABP (%)
Planned* (%)
Unplanned† (%)
*Performed electively before PCI. †Performed emergently for
laboratory. Data are presented as the percentage of patients
ACT  activated clotting time; IABP  intra-aortic ball
 left circumflex coronary artery; LMCA  left main coron
graft; TEC  transluminal extraction catheter; other abbrev
able 3. Presenting Neurologic Deficits of Patients With a
erebrovascular Accident After Percutaneous Coronary
ntervention
Deficit
Number of Patients (%)
(n  92)
otor 32 (35%)
peech 30 (33%)
ental status changes 29 (32%)
ision 14 (15%)
acial droop 14 (15%)
nresponsive 12 (13%)
ensory 8 (9%)
eadache 8 (9%)
emory 3 (3%)
taxia 3 (3%)
eizures 1 (1%)atients frequently had more than one neurologic deficit on presentation. schemic stroke, or TIA. The rates of heparin use before
CI and glycoprotein IIb/IIIa use were not significantly
ifferent between the three groups. There was a borderline
ignificantly higher use of thrombolytics before PCI (38%
s. 12% vs. 8%, p 0.060) and contrast amount (322 127
l vs. 252  134 ml vs. 246  77 ml, p  0.085) in those
ith hemorrhagic stroke, compared with those with isch-
mic stroke or TIA. Although there were no differences in
he rates of acute renal failure or new dialysis, there were
ignificantly more deaths in the hemorrhagic stroke group
han in the ischemic stroke or TIA groups (69% vs. 21% vs.
%, p  0.0001).
cteristics
CVA
20,587)
CVA
(n  92) p Value
1.8 4.4 0.09
8 34 0.42
5 25 0.96
2 26 0.24
7 15 0.003
7 36 0.83
5 51 0.44
0.5 0 1.00
7.4 12 0.095
0.05 1.1 0.048
 74 356  94 0.28
4 17 0.13
 105 262  128 0.0026
 11 23  14 0.0001
0.3 1.1 0.28
0.9 11 0.0001
1.6 4.4 0.056
0.6 2.2 0.094
0.3 0 1.00
4.4 19.6 0.0001
0.6 3.3 0.020
3.8 16.3 0.0001
dynamic compromise or complications in the catheterization
an value  SD.
mp; LAD  left anterior descending coronary artery; LCx
tery; RCA  right coronary artery; SVG  saphenous vein
as in Table 1.
igure 1. Characteristics of cerebrovascular accidents (CVAs) after percu-
aneous coronary interventions (PCIs). CT computed tomography; MRIhara
No
(n 
3
2
3
3
5
345
2
217
17
hemo
or me
oon pu
ary armagnetic resonance imaging; TIA  transient ischemic attack.
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April 7, 2004:1161–7 Cerebrovascular Events After Angioplastyischarge disposition. Of 69 patients with CVA who
urvived the hospitalization, 72% had a persistent neuro-
ogic deficit at the time of hospital discharge. All of these
eficits were in patients with ischemic or hemorrhagic
trokes and not in TIA sufferers. Of these 69 patients, most
ere discharged home (43%) without any further care
eeded. However, skilled home care was needed in 26% of
atients, nursing home or assisted living in 9%, and in-
atient rehabilitation in 22%.
ISCUSSION
ur study is the largest observational analysis of the
ncidence, predictors, and clinical implications of post-PCI
VA. In approximately 1 of 300 procedures, CVA compli-
ates PCI. Patients with this complication had higher rates
f hypertension, diabetes mellitus, previous CVA, and
mpaired renal function. They more frequently had cardiac
atheterization for urgent or emergent reasons, with a
reater prior use of thrombolytics and intravenous heparin.
hese patients underwent longer cardiac catheterization
rocedures with a greater use of contrast. Cerebrovascular
vents after PCI were associated with high rates of in-
ospital complications, including an eight-fold adjusted risk
f death, a three-fold risk of acute renal failure, and a
our-fold risk of requiring dialysis. All of the deaths oc-
urred in patients with an ischemic or hemorrhagic stroke,
nd TIA was associated with 0% mortality. However, the
ates of acute renal failure and new dialysis were the same in
ll three groups. In the patients who survived the hospital-
zation, 72% had a persistent deficit at the time of discharge.
ll of the persistent deficits were once again limited to those
ith an ischemic or hemorrhagic stroke.
The incidence of TIA and stroke in our study is within
he range reported in other studies (1,2). We found that
ypertension, diabetes mellitus, impaired renal function,
igure 2. Independent predictors of in-hospital cerebrovascular accidents
CVAs) after percutaneous coronary interventions (PCIs). CI  confi-
ence interval; OR  odds ratio.nd a history of CVA are independently associated with periprocedural CVA. Hypertension and diabetes mellitus
re both well-established risk factors for stroke (8). Al-
hough hypertension, diabetes mellitus, chronic renal dys-
unction, and a history of CVA have been well established
s risk factors for periprocedural stroke in patients under-
oing coronary artery bypass grafting (9), they have not been
eported in previous PCI studies (1,4–6,10,11). Rubenstein
t al. (12) showed a borderline significant excess of stroke in
hose with baseline renal dysfunction, as compared with
ontrol subjects, after PCI. Patients with chronic renal
nsufficiency often have concomitant cardiovascular and
erebrovascular risk factors, such as diabetes mellitus and
ypertension. In our analysis, even after adjusting for these
isk factors, chronic renal insufficiency conferred an addi-
ional risk. The mechanism of stroke in these patients with
dvanced chronic renal insufficiency may be related to
latelet dysfunction and bleeding diathesis, often present in
his group (13).
We found that thrombolytic and intravenous heparin use
efore PCI was independently associated with periproce-
ural CVA. Thrombolytic therapy in the setting of an acute
I is a well-established risk factor for both hemorrhagic
nd nonhemorrhagic stroke (14,15). Even intracoronary
hrombolytic therapy has been described as an independent
isk factor for hemorrhagic stroke (16). However, the
ssociation between intravenous heparin and stroke is less
lear. Although previous studies have found a borderline
ignificant association, the observed differences are thought
o be inconclusive because of the low number of patients
nvolved in the studies (17–19).
After adjusting for prior treatment with thrombolytics
nd intravenous heparin, urgent or emergent catheterization
onferred an additional risk for periprocedural CVA. Pos-
ible explanations for this include the greater propensity for
emodynamic compromise in these patients, which may
ncrease the risk of ischemic stroke, and the less meticulous
are in advancement of catheters through the aorta during
rgent or emergent PCI, which increases the risk of scrap-
ng aortic plaque and increases the risk of embolization to
he brain. Keeley and Grines (20) showed that scraping of
ortic plaque occurs in more than 50% of percutaneous
evascularization procedures. Furthermore, Eggebrecht et
l. (21) showed that larger-caliber catheters scrape more
ortic plaque than smaller catheters. Therefore, the in-
reased risk of CVA after urgent or emergent procedures
ay reflect the scraping of more aortic plaque in these cases,
hereby increasing the risk of emboli to the brain. Addi-
ionally, those with CVA also underwent longer procedures,
hereby further increasing the likelihood of aortic plaque
mbolization. During cardiac catheterization, the amount of
ontrast agent used in those with CVA was significantly
igher and was independently associated with this compli-
ation. This may relate to the previously described throm-
ogenic potential of some types of contrast agents (22). The
ssociation between IABP and periprocedural stroke has
reviously been reported (1,23).
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Cerebrovascular Events After Angioplasty April 7, 2004:1161–7We noted a temporal decrease in CVA when comparing
nterventions from 1998 to 2002 with those performed from
993 to 1997 (0.22% vs. 0.39%, p  0.0075). This trend
ay reflect improvement in instrumentation and techniques
nvolved with coronary interventions over the years. Both
rterial sheath and catheter sizes used in coronary interven-
ions have decreased. Smaller catheters disrupt less aortic
laque, thereby diminishing the likelihood of embolization
o the brain (20,21). Furthermore, heparin use after PCI has
ecreased, particularly after 1998, due to evidence for a lack
f its benefit (24,25). These factors may have contributed to
he observed temporal trend in CVA.
The increased rates of mortality and morbidity in patients
ith cerebrovascular complications after PCI are well
nown (1,6). However, the finding of high rates of acute
enal failure and new dialysis in patients with periprocedural
VA has not previously been reported. After accounting for
ther baseline characteristics, including a history of baseline
enal insufficiency and amount of contrast agent used,
eriprocedural CVA is independently associated with these
dverse outcomes. Perhaps, periprocedural CVA is a marker
f systemic embolization that occurs during cardiac cathe-
erization, another manifestation of which is acute renal
ailure and possibly dialysis. In our study, patients who had
CVA were older and had higher rates of hypertension and
eripheral vascular disease, which are both risk factors for
therosclerotic aortic plaque (26). Individuals with a higher
therosclerotic burden in the aorta have higher rates of
ystemic embolization, either spontaneously or from cathe-
er manipulation (26–28). In an autopsy series of 29
atients who had cholesterol emboli to the brain, 55% also
ad emboli to their kidneys (29). The majority of the
atients in this series underwent procedures involving ma-
ipulation of the aorta, and 10% of patients died due to
omplications of acute renal failure.
tudy implications. Few recommendations can be made
egarding the prevention of CVA after PCI, as most risk
actors are not modifiable, including a history of advanced
enal insufficiency, diabetes mellitus, hypertension, and
revious CVA. However, in patients with these risk factors
ho present with an acute MI, primary angioplasty should
e favored over thrombolytics. During cardiac catheteriza-
ion, careful attention should be made to minimize catheter
anipulation and exchanges. The length of the procedure
nd amount of contrast used should also be minimized.
ostprocedural anticoagulation with heparin should be
liminated in patients with uncomplicated coronary inter-
entions. In patients who present with focal neurologic
eficits soon after PCI, consideration should be given to
mmediate neuroimaging and percutaneous cerebral
ntervention.
tudy limitations. The retrospective, single-institution
ethodology and the absence of long-term follow-up are
imitations of this study. Because the incidence of peripro-
edural CVA is very low, the study does not have the power
o discriminate differences between TIA, ischemic stroke,nd hemorrhagic stroke. The incidence of TIA is likely
igher than that reported in our study, as transient neuro-
ogic deficits may not have come to the attention of
hysicians or may not have been identified. We recognize
hat the pathophysiology of CVA that occurred 48 h after
he coronary intervention may not necessarily be related to
he PCI. However, because a change in mental status was
ne of the presenting symptoms in 32% of CVA patients,
his may have led to a delayed diagnosis. Furthermore,
ostprocedural anticoagulation may have contributed to
elayed hemorrhage in CVA patients. Because of these
actors, we have chosen to include all patients, regardless of
he time frame of presentation.
onclusions. Cerebrovascular accidents complicating PCI
re rare and have decreased in incidence as interventional
echniques and instrumentation have improved. Many of
he risk factors associated with this complication are not
odifiable. With primary angioplasty replacing thrombo-
ytics as the treatment of choice for acute MI, minimization
f prolonged postprocedural anticoagulation, as well as
ontinued improvement in interventional technology and
echniques, we will likely continue to reduce this devastating
omplication.
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